Risma Lab

Publications

Zhou, ZH; Cortese, MM; Fang, JL; Wood, R; Hummell, DS; Risma, KA; Norton, AE; KuKuruga, M; Kirshner, S; Rabin, RL; et al. Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination. Vaccine. 2023; 41:4183-4189.

Huang, FS; Mangeot, C; Sucharew, H; Simon, K; Courter, J; Risma, K; Schaffzin, JK. Beta-Lactam Allergy Association with Surgical Site Infections in Pediatric Procedures: A Matched Cohort Study. Journal of the Pediatric Infectious Diseases Society. 2023; 12:123-127.

Guarnieri, KM; Xie, SS; Courter, JD; Liu, C; Ruddy, RM; Risma, KA. Distinct Characteristics and Chronology of Amoxicillin-Associated Reactions in Pediatric Acute Care Settings. Journal of Allergy and Clinical Immunology: In Practice. 2022; 10:2951-2957.e3.

Xie, SS; Guarnieri, KM; Courter, JD; Liu, C; Ruddy, RM; Risma, KA. Predictors of Acute Care Reutilization in Pediatric Patients With Amoxicillin-Associated Reactions. Journal of Allergy and Clinical Immunology: In Practice. 2022; 10:2958-2966.e3.

Droghini, HR; Abonia, JP; Collins, MH; Milner, JD; Lyons, JJ; Freeman, AF; Mukkada, VA; Risma, KA; Rothenberg, ME; Schwartz, JT. Targeted IL-4Rα blockade ameliorates refractory allergic eosinophilic inflammation in a patient with dysregulated TGF-β signaling due to ERBIN deficiency. Journal of Allergy and Clinical Immunology: In Practice. 2022; 10:1903-1906.

James, AE; West, L; Schloss, K; Nataraj, P; Urban, A; Hirsch, A; Krausz, M; Kumar, S; Raasch, J; Risma, K; et al. Treatment of STAT3-deficient hyper-immunoglobulin E syndrome with monoclonal antibodies targeting allergic inflammation. Journal of Allergy and Clinical Immunology: In Practice. 2022; 10:1367-1370.e1.

Dribin, TE; Schnadower, D; Wang, J; Camargo, CA; Michelson, KA; Shaker, M; Rudders, SA; Vyles, D; Golden, DB K; Spergel, JM; et al. Anaphylaxis knowledge gaps and future research priorities: A consensus report. Journal of Allergy and Clinical Immunology. 2022; 149:999-1009.

Lehman, HK; Yu, KO A; Towe, CT; Risma, KA. Respiratory Infections in Patients with Primary Immunodeficiency. Journal of Allergy and Clinical Immunology: In Practice. 2022; 10:683-691.e1.

Risma, KA. COVID-19 mRNA vaccine allergy. Current Opinion in Pediatrics. 2021; 33:610-617.

Xie, SS; Soler, X; Risma, KA. Perioperative anaphylaxis to intravenous vancomycin in a pediatric patient with previous topical exposures. Annals of Allergy, Asthma, and Immunology. 2021; 127:264-266.

Dribin, TE; Schnadower, D; Spergel, JM; Campbell, RL; Shaker, M; Neuman, MI; Michelson, KA; Capucilli, PS; Camargo, CA; Brousseau, DC; et al. Severity grading system for acute allergic reactions: A multidisciplinary Delphi study. Journal of Allergy and Clinical Immunology. 2021; 148:173-181.

Risma, KA; Edwards, KM; Hummell, DS; Little, FF; Norton, AE; Stallings, A; Wood, RA; Milner, JD. Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines. Journal of Allergy and Clinical Immunology. 2021; 147:2075-2082.e2.

Dribin, TE; Sampson, HA; Camargo, CA; Brousseau, DC; Spergel, JM; Neuman, MI; Shaker, M; Campbell, RL; Michelson, KA; Rudders, SA; et al. Persistent, refractory, and biphasic anaphylaxis: A multidisciplinary Delphi study. Journal of Allergy and Clinical Immunology. 2020; 146:1089-1096.

Gadoury-Levesque, V; Dong, L; Su, R; Chen, J; Zhang, K; Risma, KA; Marsh, RA; Sun, M. Frequency and spectrum of disease-causing variants in 1892 patients with suspected genetic HLH disorders. Blood Advances. 2020; 4:2578-2594.

Risma, KA; Marsh, RA. Hemophagocytic Lymphohistiocytosis: Clinical Presentations and Diagnosis. Journal of Allergy and Clinical Immunology: In Practice. 2019; 7:824-832.